Skip to main content

Volume 16 Supplement 1

Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications

Meeting abstracts

Edited by Johannes-Peter Stasch, John Burnett, Harald Schmidt, Michaela Kuhn and Franz Hofmann

Publication of this supplement has been fully funded by FEBGLA e.V. Johannes-Peter Stasch is an employee of Bayer Pharma AG, Wuppertal, Germany. He holds many patents on sGC stimulators and sGC activators. John C Burnett Jr is the chairman of the advisory board for Nile Therapeutics and is a Co-Founder and the Chief Scientific Officer for Zumbro Discovery. Mayo Clinic has licensed CD-NP to Nile Therapeutics and MANP to Zumbro Discovery. The other Supplement Editors declare that they have no competing interests.

7th International Conference on cGMP Generators, Effectors and Therapeutic Implications. Go to conference site.

Trier, Germany19-21 June 2015

Concatenated PDF V16 S1

Page 1 of 3

  1. Authors: Ruwan K Perera, Hariharan Subramanian, Alexander Froese, Daniela Hübscher, Konrad R Götz and Viacheslav O Nikolaev
    Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A12
  2. Authors: Dennis J Stuehr, Arnab Ghosh, Cynthia J Koziol-White, Kewal Asosingh, Georgina Cheng, Lisa Ruple, Jennifer Rodgers, Dieter Groneberg, Andreas Friebe, Johannes-Peter Stasch, Reynold A Panettieri, Mark A Aronical and Serpil C Erzurum
    Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A26
  3. Authors: Naveen L Pereira, Nirubol Tosakulwong, Christopher G Scott, Gregory D Jenkins, Naresh Prodduturi, Yubo Chai, Timothy M Olson, Richard J Rodeheffer, Margaret M Redfield MD, Richard M Weinshilboum and John C Burnett Jr.
    Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A37
  4. Authors: Ana I Casas, Friederike Langhauser, Vu Thao-Vi Dao, Emre Guney, Pamela WM Kleikers, Manuela García López, Jörg Menche, Albert-László Barabási, Christoph Kleinschnitz and Harald HHW Schmidt
    Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A39

Annual Journal Metrics

  • 2022 Citation Impact
    2.9 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    0.932 - SNIP (Source Normalized Impact per Paper)
    0.603 - SJR (SCImago Journal Rank)

    2023 Speed
    57 days submission to first editorial decision for all manuscripts (Median)
    178 days submission to accept (Median)

    2023 Usage
    790,731 downloads
    400 Altmetric mentions

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal